Protagonist Therapeutics, Inc (PTGX) › Net IncomeProtagonist Therapeutics, Inc (PTGX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$11.07M2015: -$14.86M2016: -$37.18M2017: -$36.96M2018: -$38.92M2019: -$77.19M2020: -$66.15M2021: -$125.55M2022: -$127.39M2023: -$78.95M2024: $275.19M2025: -$130.15M-$130.15M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$130.15M-147.3%2024$275.19M+448.5%2023-$78.95M+38.0%2022-$127.39M-1.5%2021-$125.55M-89.8%2020-$66.15M+14.3%2019-$77.19M-98.3%2018-$38.92M-5.3%2017-$36.96M+0.6%2016-$37.18M-150.2%2015-$14.86M-34.2%2014-$11.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share